IGHE and neoplasm: This confirms the impression that the anti-tumour mechanism of IgE in this trial likely reflects its ability to activate cell-mediated immunity against tumour cells and parasitic pathogens, rather than involvement in a conventional Type 1 allergic reaction4,17,34–36.